Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 5, 2016
VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis
Jesse M Damsker, Laurie S Conklin, Soheil Sadri, et al.
Clinical and Translational Gastroenterology
|
September 16, 2016
Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease
Christopher R Heier, Alyson A Fiorillo, Ellen Chaisson, et al.
Journal of Clinical Pharmacology
|
February 12, 2019
Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy
Panteleimon D Mavroudis, John van den Anker, Laurie S Conklin, et al.
Oncotarget
|
December 29, 2016
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor
Elizabeth Wells, Madhuri Kambhampati, Jesse M Damsker, et al.
Infection and Immunity
|
October 8, 2008
Binding of excreted and/or secreted products of adult hookworms to human NK cells in Necator americanus-infected individuals from Brazil
Andréa Teixeira-Carvalho, Ricardo T Fujiwara, Erik J Stemmy, et al.
Steroids
|
March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
Eric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Scientific Reports
|
April 19, 2018
The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice
Luis E F Almeida, Jesse M Damsker, Sarah Albani, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
August 26, 2019
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset
Jesse M Damsker, Michaelyn R Cornish, Priya Kanneboyina, et al.
Journal of Leukocyte Biology
|
March 10, 2011
Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection
Catherine Uyttenhove, Reece G Marillier, Fabienne Tacchini-Cottier, et al.
Life Science Alliance
|
February 13, 2019
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
Christopher R Heier, Qing Yu, Alyson A Fiorillo, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 5, 2016
VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis
Jesse M Damsker, Laurie S Conklin, Soheil Sadri, et al.
Clinical and Translational Gastroenterology
|
September 16, 2016
Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease
Christopher R Heier, Alyson A Fiorillo, Ellen Chaisson, et al.
Journal of Clinical Pharmacology
|
February 12, 2019
Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy
Panteleimon D Mavroudis, John van den Anker, Laurie S Conklin, et al.
Oncotarget
|
December 29, 2016
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor
Elizabeth Wells, Madhuri Kambhampati, Jesse M Damsker, et al.
Infection and Immunity
|
October 8, 2008
Binding of excreted and/or secreted products of adult hookworms to human NK cells in Necator americanus-infected individuals from Brazil
Andréa Teixeira-Carvalho, Ricardo T Fujiwara, Erik J Stemmy, et al.
Steroids
|
March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
Eric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Scientific Reports
|
April 19, 2018
The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice
Luis E F Almeida, Jesse M Damsker, Sarah Albani, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
August 26, 2019
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset
Jesse M Damsker, Michaelyn R Cornish, Priya Kanneboyina, et al.
Journal of Leukocyte Biology
|
March 10, 2011
Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection
Catherine Uyttenhove, Reece G Marillier, Fabienne Tacchini-Cottier, et al.
Life Science Alliance
|
February 13, 2019
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
Christopher R Heier, Qing Yu, Alyson A Fiorillo, et al.
Page
of 4